Previous close | 32.10 |
Open | 31.86 |
Bid | 0.00 x 900 |
Ask | 0.00 x 900 |
Day's range | 31.17 - 31.92 |
52-week range | 21.20 - 41.84 |
Volume | |
Avg. volume | 1,276,926 |
Market cap | 2.628B |
Beta (5Y monthly) | 2.08 |
PE ratio (TTM) | 15.86 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is proud to announce the Health Canada license of the Forma-I to address the symptoms of dry eye disease due to Meibomian gland dysfunction (MGD). Forma-I is intended for use in the periorbital area and eyelids and relieves inflammation of meibomian glands and eye irritation.